AEMDAethlon Medical, Inc.
2.780USD-5.28%Mkt Cap: 1.46M $P/E:

Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended to address un…

Key Statistics

Company
Market Cap1.46M $
Enterprise Value-3.39M $
Revenue (TTM)
Gross Profit
Net Income (TTM)-7.15M $
Revenue/Share
Last Price2.780 USD
Fiscal Year EndMar 2026
MR QuarterJun 2026
Employees9
CountryUS
SectorHealthcare
IndustryMedical Devices
ISINUS00808Y3071
Valuation
P/E (Trailing)
P/E (Forward)-4.74
PEG
EV/EBITDA0.50
EV/Revenue
P/S
P/B0.25
EPS (TTM)-14.38
EPS (Forward)-0.57
52W Range
2.6250% of range137.00
52W High137.00 USD
52W Low2.625 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-146.36%
ROA-112.92%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-7.00M $
CapEx (TTM)3.70K $
FCF Margin
FCF Yield
Net Debt-4.68M $
Net Debt/EBITDA0.69
Balance Sheet
Debt/Equity0.07
Current Ratio5.42
Quick Ratio4.76
Book Value/Sh10.89 USD
Cash/Share10.33 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay DateOct 15, 2019
Splits
Last Split1:5
Split DateAug 4, 2026
Analyst Consensus
Rating3.0 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)13.25 USD
Upside (mean)+376.6%
Target Range1.500 USD25.00 USD
$1.500+376.6% to mean$25.00
# Analysts2
Ownership
Shares Out.711.14K
Float473.54K
Insiders3.81%
Institutions9.79%
Short Interest
Short Ratio1.3d
Short % Float8.82%
Short % Out.8.80%
Shares Short46.33K
Short (prev mo.)43.68K
Technical
SMA 504.391 (-36.7%)
SMA 20011.06 (-74.9%)
Beta
S&P 52W Chg18.16%
Avg Vol (30d)40.81K
Avg Vol (10d)37.81K
Technical Indicators
RSI (14)33.8
MACD-0.4807
MACD Signal-0.6149
MACD Hist.+0.1342
BB Upper3.456 USD
BB Middle3.019 USD
BB Lower2.582 USD
BB Width28.95%
ATR (14)0.3628 USD
Vol Ratio (20d)1.02x